Inspire Medical Systems Inc Cash Flow Conversion Efficiency
Inspire Medical Systems Inc cash flow conversion efficiency. Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has a cash flow conversion efficiency ratio of 0.028x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($23.23 Million) by net assets ($825.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Inspire Medical Systems Inc (2016–2025)
Cash flow conversion efficiency of Inspire Medical Systems Inc from 2016 to 2025. This chart illustrates how Inspire Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Inspire Medical Systems Inc for real-time trading data and today's change.
Inspire Medical Systems Inc Cash Flow Conversion Ratio Explained
Inspire Medical Systems Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Inspire Medical Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inspire Medical Systems Inc ranked by their cash flow conversion efficiency. Also see Inspire Medical Systems Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Graubuendner Kantonalbank
SW:GRKP
|
0.045x |
|
Gas Malaysia Bhd
KLSE:5209
|
0.049x |
|
Aarti Industries Limited
NSE:AARTIIND
|
0.094x |
|
ZhongAn Online P & C Insurance Co. Ltd
F:1ZO
|
0.027x |
|
Jointo Energy Investment Co Ltd Hebei
SHE:000600
|
0.096x |
|
Genting Malaysia Bhd
KLSE:4715
|
0.065x |
|
H2O America
NASDAQ:HTO
|
0.051x |
|
Xizi Clean Energy Equipment Manufacturing Co Ltd
SHE:002534
|
0.030x |
Annual Cash Flow Conversion Efficiency for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Inspire Medical Systems Inc from 2016 to 2025. Review Inspire Medical Systems Inc (INSP) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $781.16 Million | $116.98 Million | 0.150x | -20.70% |
| 2024-12-31 | $689.70 Million | $130.25 Million | 0.189x | +338.55% |
| 2023-12-31 | $572.51 Million | $24.65 Million | 0.043x | +84.62% |
| 2022-12-31 | $496.01 Million | $11.57 Million | 0.023x | +126.55% |
| 2021-12-31 | $229.05 Million | $-20.12 Million | -0.088x | +61.96% |
| 2020-12-31 | $229.75 Million | $-53.05 Million | -0.231x | +3.27% |
| 2019-12-31 | $139.84 Million | $-33.38 Million | -0.239x | -109.40% |
| 2018-12-31 | $164.00 Million | $-18.69 Million | -0.114x | +98.93% |
| 2017-12-31 | $1.48 Million | $-15.79 Million | -10.641x | -491.75% |
| 2016-12-31 | $-6.61 Million | $-17.95 Million | 2.716x | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more